Correlation of cytokine levels and response to radiation therapy and/or brachytherapy in low/intermediate risk prostate cancer.

被引：0
|
作者：
Ashamalla, H
Marella, V
Feliberti, J
Kavosh, E
Guirguis, A
Fahim, O
Wise, G
机构：
[1] NY Methodist Hosp, Brooklyn, NY USA
[2] Maimonides Hosp, Brooklyn, NY 11219 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：190S / 190S
页数：1
相关论文
共 50 条
  • [21] External beam radiation therapy and brachytherapy boost versus radical prostatectomy and adjuvant radiation therapy for high-risk prostate cancer.
    Muralidhar, Vinayak
    Mahal, Brandon Arvin Virgil
    Yang, David Dewei
    Leeman, Jonathan Eric
    D'Amico, Anthony Victor
    Nguyen, Paul L.
    Orio, Peter F.
    King, Martin T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] CLINICAL RESULTS IN HYPOFRACTIONATED STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LOW-INTERMEDIATE PROSTATE CANCER.
    Bolzicco, G.
    Favretto, M. S.
    Scremin, E.
    Tambone, C.
    Tasca, A.
    Guglielmi, R.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S396 - S397
  • [23] External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
    Fischer-Valuck, Benjamin Walker
    Baumann, Brian Christopher
    Dhere, Vishal Ramesh
    Brenneman, Randall
    Gay, Hiram Alberto
    Andruska, Neal
    Brown, Simon A.
    Hershatter, Bruce
    Michalski, Jeff M.
    Patel, Sagar Anil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [24] Results from a phase II trial (NTC01902680) of ultrafocal brachytherapy for low/intermediate risk prostate cancer.
    Graft-Cailleaud, Pierre
    Malavaud, Bernard
    Portalez, Daniel
    Brun, Thomas
    Aziza, Richard
    Lusque, Amellie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [25] Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer
    Andruska, Neal
    Michalski, Jeff M.
    Carmona, Ruben
    Agabalogun, Temitope
    Brenneman, Randall J.
    Gay, Hiram A.
    Fischer-Valuck, Benjamin W.
    Baumann, Brian C.
    BRACHYTHERAPY, 2022, 21 (03) : 317 - 324
  • [26] Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy
    Markovic, Emily Schlussel
    Buckstein, Michael
    Stone, Nelson N.
    Stock, Richard G.
    BJU INTERNATIONAL, 2018, 121 (05) : 774 - 780
  • [27] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1122 - S1123
  • [28] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez-Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S123 - S123
  • [29] Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in intermediate and high-risk localized prostate cancer.
    Yin, Ming
    Monk, Paul
    Mortazavi, Amir
    Joshi, Monika
    Folefac, Edmund
    Clinton, Steven K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] External Beam Radiation Therapy With or Without Low Dose Rate Brachytherapy: Analysis of Favorable and Unfavorable Intermediate-Risk Prostate Cancer Patients
    Dess, R. T.
    Abugharib, A.
    Soni, P. D.
    Narayana, V.
    Evans, C.
    Gaber, M. S.
    Feng, F. Y.
    McLaughlin, P. W.
    Spratt, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E227 - E228
12345